Abionic

Abionic Appoints Patrick Pestalozzi as New CEO to Propel Company into Next Growth Phase A former Management Consultant, Silicon Valley executive, and Entrepreneur, Patrick brings to Abionic 3 decades of global experience, more recently as the Vice-President of Global Strategic Accounts for Mindmaze (Digital Neuro DTx) and Managing Director (CEO) at GaitUp, a Mindmaze subsidiary, where he spearheaded efforts to scale its business capability and drive international expansion. Welcome on Board Patrick! #newteammember #Abionic https://lnkd.in/exHpk9v7

Join us at the JP Morgan Healthcare conference from January 8 to 11 in San Francisco We are delighted to announce that Abionic will be taking part in the prestigious JP Morgan Healthcare Conference in San Francisco. This event is a cornerstone of the healthcare industry, bringing together innovators, thought leaders and experts from around the world. Our team will be there, ready to share the latest updates on our revolutionary sepsis test, discuss new trends and explore potential partnerships. https://lnkd.in/eZBPTdbM #Abionic #JPMorganHealthcareConference #HealthcareInnovation #Networking #SanFrancisco

Happy Holidays from the abioTEAM!

Congrès finlandais sur le sepsis. Helsinki - Espoo HUG - Hôpitaux Universitaires de Genève Hirslanden Genève Abionic #sepsis #biomarker # Pancreaticstoneprotein

DID YOU KNOW? It was estimated that almost half of all global sepsis cases occurred among children, with an estimated 20 million cases and 2.9 million global deaths in children under 5. To raise awareness about the global burden of sepsis, we have created a Sepsis Community with free resources to help you stay on top of the latest clinical developments. Join our community here: https://iii.hm/1nd5 In partnership with Abionic #Sepsis #PSP #biomarkers #ICU #criticalcare #diagnosis #sepsisawareness

We are delighted to welcome Fapon as a key partner in the development of the PSP sepsis test for the Chinese market! 🇨🇭🇨🇳 Let's continue to save lives together! #PSP #Abionic #Lascco #Fapon #sepsis

Discriminative performance of pancreatic stone protein in predicting ICU mortality and infection severity in adult patients with infection: a systematic review and individual patient level meta‑analysis 🔥 In another landmark meta-analysis on 678 patients, PSP (Pancreatic Stone Protein) showed a very good discriminative ability for both investigated study endpoints ICU mortality and infection severity 👉 Click here to know more about this study published in the journal Infection https://lnkd.in/gHDva8Ab #sepsis #PSP #biomarker #ICU #study  

Hospital and #ICU nosocomial sepsis screening for acutely ill and high-risk patients and daily measurement of PSP to diagnose nosocomial sepsis three to five days before the onset of symptoms. Learn more https://lnkd.in/eNhdbKtB Dr François Ventura Abionic #PSP #Sepsis #Biomarkers #EHR #PancreaticStoneProtein

🔈 Did you miss the Sepsis Alliance Summit on September 27 and 28, 2023? Don't worry, you can still access the session sponsored by Abionic! 👉 Click here to view Prof Andrew Shorr presentation: “The Role of Pancreatic Stone Protein (PSP) as a Novel Biomarker in the Diagnosis and Management of Sepsis” and learn more about sepsis biomarkers and early detection. https://lnkd.in/eGN5zPmC   #Sepsis #Abionic #PSP Andrew Shorr